1. dwright29
2. servigener
4. golemelin
5. lucaptr
1.golemelin 02/09/2018
Presents preliminary Phase 1 data on Tislelizumab in patients with Urothelial Carcinoma
2.dwright29 02/05/2018
Announced the commercial availability of VIDAZA (azacitidine for injection) in China
3.golemelin 01/31/2018
Great pipeline with this bio
4.MAJDAVARAN 09/27/2017
Bios are doing a lot better lately
5.servigener 01/31/2018
More DD
6.dwright29 02/12/2018
BeiGene Presents Preliminary Phase 1 Data on Tislelizumab in Patients with Urothelial Carcinoma at 2018 Genitourinary Cancers Symposium
7.servigener 01/31/2018
Good hopes with $BGNE
8.MAJDAVARAN 01/18/2018
Market really liked this>?!
9.lucaptr 02/07/2018
If you trust Maxim
10.dwright29 01/18/2018
BeiGene Announces Pricing of $750 Million Public Offering
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW